Similar Items: Segmental fructose handling may refine the temporal glucagon‐like peptide‐1–glucagon‐like peptide‐2 framework during chronic fructose exposure
- Reply to Huang et al.: ‘Segmental fructose handling may refine the temporal glucagon‐like peptide‐1/glucagon‐like peptide‐2 framework during chronic fructose exposure’
- Glucagon-Like Peptide-1 Receptor Agonists: Their Potential Role in Prediabetes
- Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Sex‐dependent responses to glucagon agonist therapies in obesity: Mechanistic insights and broader pharmacological implications
- Perceptions of Glucagon‐like Peptide 1 Receptor Agonists Among Individuals With Knee Osteoarthritis and Excess Weight: A Qualitative Study